GPNMB and amyotrophic lateral sclerosis: This indicates that UCHL1 and GPNMB are good candidate biomarkers for longevity in ALS; multivariate modeling and ROC analysis indicate that these proteins can separate patients based on survival time and may be useful to predict ALS longevity.